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.2012.10.Abstract To determine predictability of serial estimations of blood lactate levels for postoperative
outcome of head and neck cancer patients and determine validity of single versus serial estimations
for accurate prediction of outcome.
The study included 322 cancer patients assigned for major head and neck surgeries and admitted to
ICU. Data collection included age, sex, and associated comorbidities, and clinical status was deter-
mined using APACHE II score. Arterial lactate was measured at time of admission (T0), and 8-
hourly (T8, T16, T24), and percentage of change of blood lactate level was calculated versus T0
level. Patients were categorized as survivor and non-survivors, and among each group, patients were
categorized according to estimated level of blood lactate into four categories.
The mean of APACHE score at ICU admission was 16.6 ± 3.1, and mean duration of ICU and
hospital stay was 3.2 ± 1.2 and 19.3 ± 5.5 days, respectively. Fifty-two patients died for postoper-
ative mortality rate 16.1%. Non-survivors were signiﬁcantly older and had signiﬁcantly higher
APACHE score and signiﬁcantly longer ICU and hospital stay. At admission blood lactate level
was signiﬁcantly higher in non-survivors compared to survivors. All patients showed progressive
increase of blood lactate level, but non-survivors showed signiﬁcantly higher frequency of elevated
blood lactate strata compared to survivors with signiﬁcantly higher difference between both groups
at T8, T16, and T24. There was positive signiﬁcant correlation between high at admission blood
lactate level and APACHE score. Regression analysis deﬁned % of change of blood lactate at
T16, high APACHE score, high at admission blood lactate and old age as speciﬁc predictors for6291850.
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150 W.A. Ibrahim, A.S. Ahmedpostoperative mortality in descending order of speciﬁcity. Serial estimations of blood lactate are
conclusive test for follow-up of patients undergoing major surgical procedures requiring ICU
admission. Combined high APACHE score and percentage of change of blood lactate could dis-
criminate survivors from non-survivors especially 16-h after ICU admission.
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Lactate is formed by reduction in pyruvate and is metabolized
by oxidation to pyruvate in a reaction catalyzed by cytosolic
NAD-dependent lactate dehydrogenase. Pyruvate is oxidized
through the mitochondrial respiratory chain to carbon dioxide
and water with accompanying energy production. Mitochon-
drial fate of pyruvate is oxygen demanding and so if oxygen
supply is insufﬁcient or compromised or if pyruvate production
exceeds the capacity of oxidative metabolism, pyruvate will be
diverted to lactate leading to increased blood lactate levels. Such
increase in blood lactate if accompanied by decreased clearance
through the liver and heart hyperlactataemia results. Excessive
lactate production may give rise to lactic acidosis [1–4].
Measurement of blood lactate to monitor critically ill
patients for risk assessment remains under research. An
elevated serum lactate level was found to be associated with
high morbidity in patients with severe sepsis and septic shock
with a possible role for hepatic dysfunction for augmenting
serum lactate level due to either impaired lactate clearance or
excessive production [5].
The point of controversy is whether to perform a single or
serial lactate measurements and the appropriate reference
interval. Hyperlactataemia is common at admission in a
general ICU and is associated with increased mortality,
irrespective of presence of hypotension.
Shock was the commonest cause for hyperlactataemia fol-
lowed by respiratory and renal failures [6] Jat et al. [7] reported
that among pediatric septic shock patients; non-survivors had
higher blood lactate levels at admission as well as at 12 and 24 h.
The current prospective study aimed to determine the
predictability of serial estimations of blood lactate levels for
postoperative outcome of head and neck cancer patients and
to determine the validity of single versus serial estimations
for accurate prediction of outcome.
2. Patients and methods
The present study was conducted at Department of Anesthesia
and Intensive Care; National Cancer Institute From January
2009 till October 2011. After approval of the Study protocol
by the Local Ethical Committee and obtaining fully informed
written Consents. The study involved 322 cancer patients who
underwent major head and neck surgeries and admitted to the
ICU. The cases were total laryngo-pharyngectomies, total
laryngectomies, commando operations, total thyroidectomies,
and maxillectomies.
Associated comorbidities were found as diabetes mellitus,
cardiac insufﬁciency, liver cirrhosis, and chest troubles.
All cases received general anesthesia, after proper assess-
ment of the airway. In the form of IV induction with propofol
1–2 mg/kg followed by suxamethonium 1 mg/kg then intuba-tion with Armord tube was done. Few cases need Fibreoptic
Intubation. Maintenance was carried with Isoﬂurane 1–1.5
MAC and Oxygen. Fentanyl was used as narcotic intraopera-
tive. Mechanical ventilation was facilitated by Atracurium.
Arterial canula was inserted for all cases. Invasive monitoring
was used in the form of CVP and ABP &Temperature moni-
toring. Most cases were extubated postoperatively, except
few cases who need postoperative ventilation. The patients
were followed in the ICU. Serial ABGs were done. Vital signs
were followed regularly.
Data collection included age, sex, and associated comorbid-
ities. Clinical status was determined using Acute Physiology
and Chronic Health Evaluation (APACHE) II score [8]. Arte-
rial lactate was measured by blood gas analyzer (Rapilab,
Bayer Australia, Sydney, NSW, Australia) with the upper nor-
mal limit was considered about 18 mg/dl. Four samples were
obtained at time of admission (T0), and 8-hourly, there after
(T8, T16, T24), and percentage of change of blood lactate level
was calculated versus T0 level.
Patients were categorized according to the outcome as re-
gards survival into survivor and non-survivor groups and
among each group patients were categorized According to esti-
mated level of blood lactate into four categories: <18 mg/dl,
18–36 mg/dl, 36–54 mg/dl and >54 mg/dl with regard to this
study, and after power analysis, the sample size chosen was
considered adequate to detect a signiﬁcant change.
Obtained data were presented as mean ± SD, ranges, num-
bers and ratios and median values. Results were analyzed
using paired t-test, Wilcoxon test for unrelated data (Z test)
and Chi-square test. Possible correlation was investigated
using Pearson linear regression. Speciﬁcity of evaluated
parameters as predictors for mortality was evaluated using
the receiver operating characteristic (ROC) curve analysis
judged by the area under the curve (AUC) and was stratiﬁed
using Regression analysis (Stepwise method). Statistical
analysis was conducted using the SPSS (Version 15, 2006)
for Windows statistical package. p value <0.05 was considered
statistically signiﬁcant.
3. Results
The study included 322 cancer patients who underwent major
head and neck surgeries. Mean age of enrolled patients was
64.4 ± 9.2; range: 44–84.
There were 187 males (58.1%) and 135 females (49.1%).
Two hundred and thirteen patients (66.1%) had additional
comorbidities in varied combinations; but diabetes mellitus,
history of cardiac affection are the commonest. All patients
passed smooth intraoperative course, and all admitted immedi-
ately to ICU with a mean APACHE Score of 16.6 ± 3.1;
range: 6–24. Mean duration of ICU stay was 3.2 ± 1.2; range:
2–7 days, and mean total hospital stay was 19.3 ± 5.5; range:
Table 1 Patients’ characteristics and hospital data.
Survivors Non-survivors Total
Number
270 (83.9%) 52 (16.1%) 322 (100%)
Age (years) 63.8 ± 9.4 (44–82) 67.7 ± 7.5 (56–84)* 64.4 ± 9.2 (44–84)
Gender
Males 156 (57.8%) 31 (59.6%) 187 (58.1%)
Females 114 (42.2%) 21 (40.4%) 135 (41.9%)
Co-morbidities
Diabetes mellitus 198 (73.3%) 34 (65.4%) 232 (72%)
History of cardiac disease 67 (24.8%) 17 (32.7%) 84 (26.1%)
Hypertension 103 (38.1%) 19 (36.5%) 122 (37.9%)
Renal impairment 45 (16.7%0 9 (17.3%) 54 (16.8%)
APACHE score
16.3 ± 2.9 (6–19) 18.2 ± 3.4 (10–24)* 16.6 ± 3.1 (6–24)
Hospital stay data
ICU (days) 2.9 ± 0.9 (2–5) 4.5 ± 1.5 (2–7)* 3.2 ± 1.2 (2–7)
Total (days) 18.7 ± 4.8 (7–26) 22.6 ± 7.3 (10–36)* 19.3 ± 5.5 (7–36)
Data are presented as mean ± SD and numbers; ranges and percentages are in parenthesis.
Percentages were calculated in relation to the corresponding total group number.
* Signiﬁcant versus survivors.
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Figure 1 Patients distribution according to survival outcome
and blood lactate level strata.
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Figure 2 Mean blood lactate levels estimated in studied patients
categorized according to survival outcome throughout 24-h ICU
stay.
Serial estimations of blood lactate predict postoperative outcome in cancer patients 1517–36 days. Throughout hospital stay, two hundred and seventy
patients were discharged alive from the hospital. The survival
rate was 83.9%. There was nonsigniﬁcant difference between
survivors and non-survivors as regards gender distribution
and frequency of co-morbidities. However, non-survivors were
signiﬁcantly older and had signiﬁcantly higher APACHE score
at time of admission to ICU with signiﬁcantly longer ICU and
hospital stay, (Table 1).
The underlying causes of death were mainly the associated
morbidities, sepsis, and postoperative surgical complications.
Mean blood lactate level estimated at time of admission to
ICU was signiﬁcantly (p< 0.05) higher in non-survivors
compared to survivors. However, throughout 24-h ICU stay,
all patients showed progressive increase in mean blood lactate
level, irrespective of survival outcome. At 24-h after ICU
admission, 207 patients (64.3%) had blood lactate level below
the maximum of normal blood lactate level (<18 mg/dl), while
115 patients (35.7%) had blood lactate level exceeding themaximum of normal blood lactate level (18 mg/dl); ﬁve
patients (1.6%) had blood lactate level of >54 mg/dl, four
patients (1.2%) had blood lactate level >36 mg/dl but
<54 mg/dl, and 106 patients (32.9%) had blood lactate level
in range of 18–36 mg/dl (see Fig. 1).
Non-survivors showed signiﬁcantly higher frequency of ele-
vated blood lactate strata compared to survivors, (X2 = 6.6 at
T8, 10.456 at T16 and 11.215 at T24, p< 0.05 for all).
Moreover, mean blood lactate level showed signiﬁcantly
higher difference between both groups at T8, T16, and T24,
(Table 1, Figs. 2 and 3). There was a positive signiﬁcant corre-
lation between high at admission blood lactate level and
APACHE score, (r= 0.178, p= 0.001) (see Table 2).
Considering the signiﬁcant difference between survivors
and non-survivors as regards age, APACHE score and at
admission blood lactate level; ROC curve analysis graded
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Figure 3 ROC curve analysis of the evaluated parameters as predictors for mortality.
Table 2 Blood lactate levels estimated in studied patients categorized according to survival and blood lactate strata.
Time Data Survivors Non-survivors Total
Admission Frequency <18 mg/dl 270 (83.9%) 52 (16.1%) 322 (100%)
18–36 mg/dl 0 0 0
>36–54 mg/dl 0 0 0
>54 mg/dl 0 0 0
Levels (mg/dl) 13 ± 1.88 13.9 ± 1.9* 13.12 ± 1.9
(9.2–16.2) (10.3–17.8) (9.2–17.8)
8-h after ICU admission (T8) Frequency <18 mg/dl 247 (91.5%) 41 (78.5%) 288 (89.4%)
18–36 mg/dl 23 (8.5%) 11 (21.2%) 34 (10.6%)
>36–54 mg/dl 0 0 0
>54 mg/dl 0 0 0
Levels (mg/dl) 15 ± 3.48 17.23 ± 4.1* 15.33 ± 3.67
(9.2–23.4) (11.6–29.6) (9.2–29.6)
16-h after ICU admission (T16) Frequency <18 mg/dl 206 (76.3%) 22 (42.3%) 228 (70.9%)
18–36 mg/dl 64 (23.7%) 25 (44.2%) 89 (27.6%)
>36–54 mg/dl 0 3 (5.7%) 3 (0.9%)
>54 mg/dl 0 2 (3.8%) 2 (0.6%)
Levels (mg/dl) 16.1 ± 5 25.17 ± 11.64* 18.42 ± 7.61
(9.2–27.6) (12.3–50.5) (9.2–50.5)
24-h after ICU admission (T24) Frequency <18 mg/dl 188 (69.6%) 19 (36.5%) 207 (64.3%)
18–36 mg/dl 82 (30.4%) 24 (46.2%) 106 (32.9%)
>36–54 mg/dl 0 4 (7.7%) 4 (1.2%)
>54 mg/dl 0 5 (9.6%) 5 (1.6%)
Levels (mg/dl) 16.74 ± 5.38 26.91 ± 13.36* 18.38 ± 8.17
(9.2–29.6) (12.3–60.4) (12.3–60.4)
Data are presented as mean ± SD and numbers; ranges and percentages are in parenthesis.
* Signiﬁcant versus survivors.
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change of blood lactate level at T8, T16, and T24, according
to AUC for each as speciﬁc predictor for mortality in the
following descending order: percentage of change of blood
lactate at T16 (AUC= 0.818), percentage of change of
blood lactate at T24 (AUC= 0.783), high APACHE score
(AUC= 0.706), percentage of change of blood lactate at
T8 (AUC= 0.678), high at admission blood lactate(AUC= 0.629), and lastly, older age (AUC= 0.617) (Table
3, Fig. 3).
Regression analysis deﬁned percentage of change of blood
lactate at T16 as speciﬁc predictor in four models, high
APACHE score in three models, followed by high at admission
blood lactate in two models followed by old age in one model
(Table 4).
Table 3 Speciﬁcity of evaluated parameters as predictors for mortality as judged by ROC curve analysis.
Test parameter AUC Std. error Signiﬁcance 95% Conﬁdence interval
Lower bound Upper bound
Old age 0.617 0.042 0.007 0.535 0.700
High APACHE 0.706 0.047 <0.001 0.614 0.798
High admission blood lactate 0.629 0.041 0.003 0.548 0.710
Percentage of change versus T0 lactate level
T8 0.678 0.032 <0.001 0.614 0.741
T16 0.818 0.026 <0.001 0.766 0.869
T24 0.783 0.029 <0.001 0.726 0.839
AUC: area under curve, Std. error: standard error.
Table 4 Predictability of evaluated parameters for mortality as judged by Regression analysis.
Model Variable b Std. error t Sig.
Model I Percentage of change of blood lactate at T16 0.420 0.001 8.278 <0.001
Model II Percentage of change of blood lactate at T16 0.443 0.001 9.045 <0.001
High APACHE 0.261 0.006 5.327 <0.001
Model III Percentage of change of blood lactate at T16 0.465 0.001 9.672 =0.003
High APACHE 0.227 0.006 4.689 =0.008
High at admission blood lactate level 0.198 0.009 4.060 =0.040
Model IV Percentage of change of blood lactate at T16 0.470 0.001 9.858 <0.001
High APACHE 0.195 0.006 3.954 <0.001
High at admission blood lactate level 0.202 0.009 4.192 <0.001
Old age 0.131 0.002 2.703 =0.007
b: Standardized coefﬁcient, Std error: standard error, t: paired t-test.
% of change was calculated as follows: ([(T8)  (T0)]/[T0]) · (100)).
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The prognostic yield of estimation of serum levels of biomark-
ers for prediction of outcome of critically ill patients admitted
to ICU is still a matter of controversy despite the settled
advantages. These advantages involve that it spares the need
for patients transfer, easiness of repetition and interpretation,
instrumental availability, and low cost.
Disturbed redox milieu is one of overwhelmed events that if
misdiagnosed could induce critical situation in an already crit-
ically ill patient. Additionally, cancer is one of the diseases that
depend on disturbed redox milieu for its pathogenesis and/or
induces such disturbance. Disturbed mitochondrial respiratory
chain cascades affect cellular redox state with subsequent
reduction of cellular energetic sources and accumulation of un-
wanted intermediate reactants that may be harmful to the
body function [9–11].
Elevated blood lactate is one example for such events; the
current study reported steadily increasing postoperative blood
lactate levels in studied patients admitted to ICU with signiﬁ-
cantly higher levels in those died during their ICU or hospital
stay compared to those discharged alive in all examined sam-
ples with a positive signiﬁcant correlation between high at
admission blood lactate level and APACHE score. These data
points to a correlation between clinical evaluation of disturbed
patients’ physiological status and disturbed respiratory chain
function manifested as shift of pyruvate metabolism to lactate
as end product. Both APACHE score and blood lactate level,at ICU admission, were signiﬁcantly higher in non-survivors
compared to survivors indicating a close relation with bad
prognosis. ROC curve analysis documented this relation con-
sidering both in addition to old age as predictors for bad
outcome.
These ﬁnding supported that previously reported in litera-
ture; Cheung et al. [12] reported that non-survivors had higher
lactate concentrations at admission to pediatric ICU than sur-
vivors. Singhal et al. [13] found lactate and base deﬁcit were
signiﬁcantly higher in non-survivors compared with survivors,
and both were independently signiﬁcant for predicting mortal-
ity. Li et al. [14] reported that blood lactate level >2.7 mmol/L
was associated with 9.3-fold-higher odds for postoperative
complications and concluded that initial serum lactate level
is signiﬁcantly associated with postoperative complications
and can independently predict in-hospital morbidity after
major abdominal surgery. Alves et al. [15] detected that after
cardiac surgeries, higher levels of arterial lactate upon ICU
admission were observed in patients who had renal
complications and for surgeries with CPB and in those patients
who died.
Through the current study, serial blood lactate levels at 8,
16, and 24-h after admission to ICU were signiﬁcantly higher
in non-survivors compared to survivors with progressive sig-
niﬁcant elevations till 24-h sample. Moreover, the percentage
of change of blood lactate levels showed progressive increase
and Regression analysis deﬁned increased percentage of
change at T16 as the speciﬁc predictor which maintained its
signiﬁcance in four models of analysis. These data indicated
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between blood levels is a more accurate and speciﬁc predictor
for mortality.
In hand with these data, Cheung et al. [12] reported that se-
rial lactate determination accurately predicts survival and may
help differentiate survivors with adverse outcome from those
with intact neurodevelopment in early childhood. Rocha
et al. [16] assessed the preoperative, immediate, 3, 6-h, and
1st day postoperative serum lactate and found increased levels
in immediate postoperative estimates but returning to baseline
at 24 h, and patients who died had raised and maintained
immediate postoperative lactate. Higher immediate and 3-h
postoperative serum lactate level best discriminated mortality
with area under the curve of 0.68. Hajjar et al. [17] suggested
that lactate and standard base deﬁcit measurement should be
included in the routine assessment of patients with cancer
admitted to ICU with sepsis, septic shock, or after high-risk
surgery; these markers may be useful in the adequate alloca-
tion of resources in this population.
Combined high APACHE score, high serial changes of
blood lactate and old age were found to be the signiﬁcant spe-
ciﬁc predictors for mortality among patients enrolled in the
current study. In support of these data, Basile-Filho et al.
[18] found the differences in blood lactate levels were statisti-
cally signiﬁcant between survivors and non-survivors at the
end of the surgery and concluded that determination of the
data was effective in predicting early mortality after orthotopic
liver transplantation.
Murtuza et al. [19] identiﬁed minimum blood lactate level
within the ﬁrst 24-h after the Sano-Norwood procedure as a
highly discriminatory predictor of perioperative mortality.
Allen [20] reported that although the presence of hyperlacta-
taemia upon ICU admission appears to be associated with high
mortality and morbidity, signiﬁcant overlap between survivors
and non-survivors means that non-survivors cannot be pre-
dicted from at admission lactate measurement but persistently
elevated postoperative lactate is associated with increased mor-
bidity and mortality in the pediatric cardiac population.
It could be concluded that serial estimations of blood
lactate is a conclusive test for follow-up of cancer patients
undergoing major surgical procedures requiring ICU admis-
sion and combined high APACHI score and percentage of
change of blood lactate level could discriminate survivors from
non-survivors with high speciﬁcity especially at 16-h after ICU
admission.
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